Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
JC polyomavirus mutants escape antibody-mediated neutralization.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Biogen Idec receives notification of PDUFA date extension
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Epigenetics of Multiple Sclerosis: An Updated Review.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Contribution of different relapse phenotypes to disability in multiple sclerosis.

Pages